OREANDA-NEWS. Sonova Holding AG, the world’s leading provider of hearing solutions, announces today that its Board of Directors nominates Lynn Dorsey Bleil as a new board member for election at the next Annual General Meeting in June 2016. The company also announces that John J. Zei will retire at the same time from the Board since he has reached the mandatory retirement age.

Ms. Lynn Dorsey Bleil (born in 1963, US citizen) recently retired as Senior Partner (Director) from McKinsey & Company in the US after more than 25 years of advising senior management and boards of leading healthcare companies on corporate and business unit strategy, mergers and acquisitions, and public policy across all segments of the healthcare value chain. She is a Non-Executive Director at DST System since 2014 and Stericycle since 2015. Ms. Bleil holds a Bachelor's Degree in Chemical Engineering from Princeton University and a Master's Degree in Business Administration from the Stanford University Graduate School of Business.

Robert F. Spoerry, Chairman of the Board of Directors of Sonova Holding AG, stated, “Ms. Bleil’s extensive experience in Healthcare Management Consulting will bring valuable strategic perspectives to Sonova. We look forward to her successful election and believe she will be a strong addition to the Board of Directors.”

Mr. Spoerry added, “I want to sincerely thank John Zei for his remarkable support, leadership and numerous contributions to the company over the last 6 years. His vast experience, deep understanding of the hearing aid industry and his dedication to Sonova were highly beneficial over his tenure. We all wish him well for the future.”

Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH1012549785) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or under the applicable securities laws of any state of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act and in compliance with applicable state securities laws, or outside the United States of America to non-U.S. Persons in reliance on Regulation S under the U.S. Securities Act.